Sterling Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 122 shares of ARWR stock, worth $2,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122Holding current value
$2,638% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
89.3MCall Options Held
291KPut Options Held
503K-
Black Rock Inc. New York, NY15.7MShares$339 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$265 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$192 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$137 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$106 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.29B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...